| Title | Date | PubMed ID |
|---|
| TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2. | 2015 Feb | 25359215 |
| Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4. | 2014 Sep | 24868011 |
| Dissociation and re-association studies on the interaction domains of mannan-binding lectin (MBL)-associated serine proteases, MASP-1 and MASP-2, provide evidence for heterodimer formation. | 2014 May | 24424083 |
| Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44. | 2013 Aug 1 | 23785123 |
| Monospecific inhibitors show that both mannan-binding lectin-associated serine protease-1 (MASP-1) and -2 Are essential for lectin pathway activation and reveal structural plasticity of MASP-2. | 2012 Jun 8 | 22511776 |
| Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4. | 2012 Jan | 22071314 |
| Mannan-binding lectin and mannan-binding lectin-associated serine protease 2 in acute pancreatitis. | 2011 Oct | 21926545 |
| Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation. | 2010 Oct 1 | 20817870 |
| Engineering novel complement activity into a pulmonary surfactant protein. | 2010 Apr 2 | 20118239 |
| Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. | 2010 Apr | 20002787 |